James Investment Research Inc Kamada LTD Transaction History

James Investment Research Inc

  • $853 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021
SELL
$6.02 - $8.06 $292,030 - $390,990
-48,510 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$6.3 - $8.46 $315 - $423
50 Added 0.1%
48,510 $314,000
Q2 2020

Jul 24, 2020
BUY
$5.37 - $9.45 $25,265 - $44,462
4,705 Added 10.75%
48,460 $376,000
Q1 2020

Apr 22, 2020
BUY
$4.56 - $7.13 $199,522 - $311,973
43,755 New
43,755 $255,000

Others Institutions Holding KMDA

# of Institutions
33
Shares Held
6.48M
Call Options Held
200
Put Options Held
0
View Full List

About KAMADA LTD

KMDA Quotes by TradingView
  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $271M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email